Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
Keytruda (pembrolizumab) - Merck (MSD)
https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-8-11-june-2026_en.pdf
 
Sep 6, 2026
 
Prev Next